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ABSTRACT: To expand the role of private managed care plans in Medicare, the Medicare 
Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) provided Medicare 
Advantage plans with significant increases in monthly payment rates, beginning March 2004. 
About one-half of the payment increases were used by plans to reduce enrollee premiums and 
cost-sharing and enhance benefits; providers received most of the rest. Premiums had already 
begun to decrease in the Medicare Advantage program in early 2004 for the first time in several 
years, but the payment increases led to further declines—average monthly premiums dropped from 
$34 to $25 after the increases. The payment rate increases also slowed the trend toward generic-
only drug coverage. Overall, average out-of-pocket costs declined to 2003 levels, although 
managed care enrollees in good health experienced a higher percentage reduction in out-of-
pocket spending than those in poor health. 
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ARE THE 2004 PAYMENT INCREASES HELPING TO STEM 
MEDICARE ADVANTAGE’S BENEFIT EROSION? 
 
OVERVIEW 
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) 
made significant changes to expand the role of private managed care plans in Medicare. 
MMA increased payments to these plans—formerly known as Medicare+Choice, now 
called Medicare Advantage (MA)—substantially, as of March 2004. In 2006, other changes 
will include the addition of regional preferred provider organizations (PPOs) and a new 
method of paying plans to include a component based on competitive bidding. This issue 
brief examines trends in MA benefits and premiums in 2004, paying particular attention to 
the impact of the payment increases. On average, these payments rose 10.9 percent 
(weighted by plan enrollment) over 2003 levels and 7.4 percent over the originally slated 
2004 payment schedule.1 Highlights of the findings include: 
 
• Overall, about one-half of the 2004 MMA increase was used by plans to reduce 
enrollee premiums and other cost sharing or to enhance benefits.2 Most of those 
benefit changes were used to reduce plan premiums, which dropped an average of 
$9 per month. 
• Average out-of-pocket costs declined to the 2003 level. Although all managed care 
enrollees received the same dollar benefit, healthier managed care enrollees 
experienced a higher percentage reduction in out-of-pocket spending than did 
those in poor health. 
• The portion of plans offering prescription drug coverage remained about the same. 
However, among those plans that offer drug coverage, a higher proportion now 
cover brand name drugs, as opposed to only generics. 
• Coinsurance for physician services was reduced slightly; the share of plans with any 
cost-sharing for hospital services remained about the same. 
• The availability of coverage for services not covered by Medicare—dental, vision, 
hearing—increased slightly. 
 
BACKGROUND 
With support from The Commonwealth Fund, Mathematica Policy Research (MPR) has 
been tracking trends in Medicare Advantage’s benefits and premiums since the program’s 
inception in 1998.3 During this period, MPR has documented a downslide—a steady 
increase in enrollees’ premiums and decline in benefits, particularly for enrollees in poor 
health. Many health plans increased cost-sharing for Medicare services and offered fewer 
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additional benefits for uncovered items, such as prescription drugs. These and other cost-
saving actions were made in response to changes in the Balanced Budget Act of 1997 and 
resulted in lower payment increases and greater pressure by providers to raise their 
payments.4 
 
In 2003, MMA aimed to increase the role of private plans and to stabilize the 
market by providing additional payments to plans in the two years between its enactment 
and the implementation of other changes slated for 2006, like the drug benefit and 
addition of regional plans.5 Prior to MMA, plans received the highest of the following 
four monthly county rates for enrollees served by the plan: 
 
• a floor, or minimum level payment, of $535 per enrollee for rural counties 
• a floor of $592 per enrollee for urban counties 
• a minimum update of 2 percent over the county’s previous year rate 
• a blend rate combining increases in spending for the county and nation as a whole, 
to be considered only if it were budget neutral, which applied in 2000 alone, and 
not 2001 to 2004. 
 
These older rates were used in January and February 2004, before the MMA changes went 
into effect. 
 
Effective March 2004, MMA authorized a fifth method of payment: 100 percent 
of the average county costs in traditional fee-for-service (FFS) Medicare. It changed the 
method for calculating the minimum update, effectively increasing it from 2 percent to 
the national Medicare growth rate percentage of 6.3 percent in 2004. This update applied 
to all counties (including floor counties) and meant that plans were guaranteed at least a 
6.3 percent increase relative to 2003, regardless of category. Finally, the MMA eliminated 
the budget neutrality requirement on the blended rate update. On average, the largest 
percentage increases went to plans serving enrollees in the newly established category of 
100 percent of FFS rate (Table 1). Forty-one percent of enrollees fell in this category, with 
an average increase of 15.3 percent over 2003 rates. All counties, regardless of type, 
benefited from the MMA payment increases.6 
 
The Congressional Budget Office estimated the total cost of the additional 
payments at $0.5 billion in 2004.7 The Medicare Payment Advisory Commission 
estimated that the increases raised average plan payments from 103 percent to 107 percent 
of estimated costs for similar beneficiaries in traditional FFS Medicare.8 The amount of the 
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additional payments varied by county and the rate category into which the county fell. For 
this reason, we also evaluate how enrollees in different types of counties fared. 
 
By statute, MA plans were required to use the additional payments to: 1) reduce 
enrollee premiums or cost-sharing; 2) enhance benefits; 3) stabilize provider networks; or 
4) maintain a stabilization fund to offset future premium increases or benefit cuts, though 
such funds had to be used by 2005. According to the Centers for Medicare and Medicaid 
Services (CMS), about one-half the funds made available to plans went directly to 
beneficiaries as reduced premiums, lowered cost-sharing, or enhanced benefits (Figure 1). 
The remaining money was used largely to enhance provider payments (42%).9 
 
This analysis of plan benefits and premiums relies on a database developed by 
MPR using information from Medicare Health Care Compare, a database of plan benefit 
packages maintained by CMS.10 (See appendix for more information.) 
 
OVERALL TRENDS IN MEDICARE ADVANTAGE PREMIUMS 
AND BENEFITS 
Premiums 
From 1999 to 2003, the average monthly premium for enrollees in Medicare managed 
care plans increased almost fivefold, from $6 in 1999 to over $37 in 2003 (Figure 2). 
However, in early 2004, prior to implementation of the MMA, the trend in premiums 
began to reverse itself. Monthly premiums in January to February of 2004 averaged $34. 
Although this is considerably higher than historic levels, it marked the first ever decline in 
average MA premiums. When the payment increases mandated by MMA went into effect 
in March 2004, monthly premiums declined by an additional $9. As a result, more 
enrollees were in zero-premium plans—packages that require no premium beyond the 
Part B premium (Table 2). In January and February 2004, 46 percent of enrollees were in 
packages with a zero premium. This represents an increase over 2003 but is still far below 
the program’s 1999 peak, when nearly 80 percent of enrollees were in zero-premium 
plans. After the March 2004 payment rate increases, the percentage of enrollees in zero-
premium plans increased to 56 percent. The share of enrollees with a monthly premium 
greater than $50 decreased. 
 
Prescription Drug Coverage 
In 2002, Medicare managed plans began cutting drug benefits by shifting toward generic-
only prescription drug coverage (Figure 3). This trend continued through the beginning 
of 2004. In January 2004, overall levels of drug coverage remained stable relative to 2003, 
with about 69 percent of MA enrollees provided with some drug coverage in their basic 
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plans. However, in terms of brand-name drugs, coverage declined over the same period. 
In 2003, 41 percent of MA enrollees had some brand-name coverage; by January 2004, 
the number had fallen to 25 percent. 
 
The MMA payment increases reversed the trend toward generic-only coverage to 
some extent. While very few enrollees who lacked drug coverage before March 2004 
gained it after the payment increases, there was a significant shift toward covering brand-
name drugs. Brand-name drug coverage increased from 25 percent to 33 percent, but 
coverage remains limited. In March 2004, more than one-half of enrollees with brand-
name drug coverage (57%) had an annual limit of $1,000 or less (Table 3). The percentage 
of enrollees with more than $2,000 in annual brand-name drug coverage increased from 
14 percent in January 2004 to 25 percent in March. There was little change in 
prescription drug copayments among plans that cover only generic drugs. Among plans 
that cover brand-name drugs and generics, there was a small reduction in copayments. 
 
Copayments for Medical and Hospital Services 
Prior to the payment increases in 2004, private Medicare plans attempted to constrain 
monthly premium increases by raising cost-sharing requirements on medical and hospital 
services. Many plans used the MMA payment increases to reverse this trend by reducing 
the physician visit copayments. The percentage of enrollees with a primary care physician 
copayment of more than $15 was cut in half from 22 percent in January–February 2004 to 
11 percent in March 2004 (Table 4). There was a similar trend in specialist visit 
copayments. By March 2004, average copayments for primary care and specialist visits 
were below those in 2003. 
 
Very few plans, however, used their additional funding to eliminate cost-sharing 
requirements for more intensive services, such as hospital, X-ray, or laboratory services. 
 
Supplemental Benefits 
One attractive aspect of MA plans has been the inclusion of benefits not covered under 
traditional FFS Medicare, such as prescription drugs and dental, vision, and hearing care. 
However, coverage of these supplemental benefits has declined over time as health plans 
tightened their packages. The increased payments from the MMA reversed this trend. By 
March 2004, more enrollees had coverage of dental, vision, hearing, and podiatry services 
compared with 2003 (Table 5). The only exception to the this trend of supplemental 
benefits is chiropractic services: slightly fewer enrollees had chiropractic benefits in 2004 
than did in 2003. Hearing benefits received the largest coverage increase, rising from 54 
percent of enrollees in January 2004 to 62 percent in March 2004. 
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Overall Impact of Changes on Out-of-Pocket Spending 
On average, the changes made in response to MMA reduced overall enrollee out-of-
pocket spending to about the same level as 2003 (Figure 4). Compared with estimated 
levels in January–February 2004, average annual out-of-pocket costs declined 8 percent in 
March 2004, from $2,119 to $1,942. The reduction puts out-of-pocket costs levels 
roughly on par with 2003 levels ($1,964), but still much higher than the 1999 level of $976. 
 
Reduction in premiums created the biggest change in beneficiaries’ out-of-pocket 
costs. Annual out-of-pocket spending for MA premiums declined 33 percent from January 
2004 to March 2004 (Table 6). Healthier managed care enrollees—who are less likely to 
use services and incur associated point-of-service charges than are sicker enrollees—
benefited the most in terms of cost reduction. These beneficiaries experienced a nearly 10 
percent drop in out-of-pocket spending. While enrollees in poor health received a similar 
reduction in terms of absolute dollars, they only saw a 5 percent reduction in out-of-
pocket costs. As of March 2004, estimated out-of-pocket spending for enrollees in poor 
health was 3.7 times that of their healthier counterparts. 
 
VARIATION IN EFFECTS BY RATE CATEGORY 
Health plans in counties receiving the new 100-percent-of-average-FFS-costs rate 
received the largest payment increases from the MMA, followed by the few health plans 
that were in blended-rate counties. Not surprisingly, these high-payment update counties 
also experienced the largest premium reductions. Monthly premiums in health plans in the 
100-percent-of-FFS counties declined by nearly $15, to $19 in March 2004 (Table 7). 
Even prior to MMA, premiums in these counties had started to fall, declining $7 from 
2003 levels to $33 per month in January 2004. Blended-rate counties experienced similar 
trends, with average monthly premiums declining from $81 in 2003 to $78 in January 
2004, and to $64 in March 2004. While all types of counties saw declines in average 
premiums, the other three rate categories experienced smaller decreases, generally around 
$4 to $5 after the payment increases became effective. 
 
MA enrollees in 100-percent-FFS counties also benefited the most from 
enhancements in prescription drug coverage (Table 8). In 2004, the percentage of 
enrollees in 100-percent-of-FFS counties with no drug coverage declined from 34 percent 
in January–February 2004 to 29 percent by March. During the same period, brand-name 
prescription drug coverage nearly doubled. However, benefit levels in counties paid at 100 
percent of FFS remain below levels in counties where payment rates are above FFS 
spending levels. 
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CONCLUSION 
By authorizing the payment increases to MA plans, Congress intended to stabilize, and 
potentially reinvigorate, the Medicare managed care program before the full 
implementation of the prescription drug benefit and regional PPO system in 2006. Plans 
were required to use the additional funds to enhance benefits, to enhance access through 
higher provider payments, or to put into a fund for later use. 
 
There is insufficient information to determine the impact that the additional 
payments made on providers—a group that received 42 percent of the increased payments. 
But Congress and CMS hoped that increases in provider payments would help plans 
stabilize their networks and improve access for beneficiaries. 
 
The impact on plans and beneficiaries is more clear. This analysis shows that many 
plans reduced premiums and physician office copayments, and, to a limited extent, 
improved drug and other supplemental benefit coverage. These changes—particularly 
premium reductions—provide gains for all enrollees, as opposed to targeted changes that 
benefit enrollees in poorer health who use more health care services. Because plans had to 
act quickly, it is possible that organizations made the changes that were easiest to 
execute.11 
 
MA enrollees in the newly established, 100-percent-of-FFS-costs counties 
comprise the largest contingent of current program enrollment (41%). Enrollees in these 
counties benefited the most from the MMA changes, with slightly less than 900,000 
enrollees seeing a reduction in monthly premiums, nearly 625,000 getting some 
enhancement to their prescription drug coverage, and about 400,000 experiencing a 
reduction in primary care physician copayments (Table 9). 
 
It is too early to gauge whether the payment changes are enough to reverse the 
downslide in private plans’ participation in the MA program and beneficiaries’ enrollment 
in these plans in the long term. CMS reports of enrollment and pending applications do 
show some impact. MA beneficiary enrollment increased by 90,000 from January to 
October 2004, and the agency reports 31 pending applications for new MA plans and an 
additional 21 pending applications for service area expansions.12 However, despite these 
recent events, the share of Medicare beneficiaries in private plans still remains relatively 
low (12.7 percent as of October 2004), when compared with the entire Medicare 
population. 
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TABLES AND FIGURES 
 
 
 
Table 1. MMA Payment Rate Increases by Payment Rate Category 
Rate Category 
Percent of 
MA Enrollees 
Average 
2003 Payment
Average 
Jan–Feb 2004 
Payment 
Average 
Mar–Dec 2004 
Payment 
Total Payment 
Increase (%) 
2003 to 
Mar–Dec 2004
Overall 100.0% $620 $640 $689 10.9% 
Rural Floor 4.1% $500 $525 $544 8.8% 
Urban Floor 26.0% $564 $592 $614 8.9% 
Minimum Update 21.8% $717 $733 $763 6.3% 
100% FFS 40.7% $619 $636 $713 15.3% 
Blended Update 7.3% $608 $624 $667 9.8% 
Notes: Information excludes counties in Guam and the Virgin Islands, but includes Puerto Rico. All data were weighted 
by the number of MA enrollees in a county in September 2003. Data presented includes only demographic payment 
rates, which account for 70 percent of total plan payments in 2004. 
Source: Achman and Gold, February 2004. 
 
 
 
 
Figure 1. MA Health Plans Use of
Increased Payments from the MMA 
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Source: “Review Shows Beneficiaries in Medicare Advantage Plans Will See Better Benefits, Lower Costs,” 
Centers for Medicare & Medicaid Services, February 27, 2004.
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Figure 2. Average Medicare Advantage Premiums, 
1999–2004 
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Note: With the exception of the January–February 2004 data, all other data is weighted by March
enrollment of each year. January–February 2004 data is weighted by February 2004 enrollment.
Source: MPR Analysis of Medicare Compare for The Commonwealth Fund.
Dollars
 
 
 
 
Table 2. Monthly Premiums in Medicare Advantage Plans, 
1999 and 2003–2004 
 Percentage of Enrollees 
 1999 2003 
Jan–Feb 
2004 
Mar–Dec
2004 
Reduced Premium/$0 79.6 38.5 46.3 55.7 
Less than $20.00 3.1 1.3 2.0 3.0 
$20.00–$49.99 13.5 25.3 19.3 17.5 
$50.00 or more 3.2 34.9 32.4 23.9 
Unknown 0.6 0.0 0.0 0.0 
     
Mean $6.37 $37.29 $34.29 $25.31 
     
Mean if premium does not equal $0 $32.11 $60.45 $62.01 $52.64 
Number of Contract Segments/Enrollees 6,254,616 4,546,635 4,500,990 4,503,282 
Note: With the exception of the January–February 2004 data, all other data is weighted by March enrollment 
of each year. January–February 2004 data is weighted by February 2004 enrollment. 
Source: MPR analysis of Medicare Compare for The Commonwealth Fund. 
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Figure 3. Changes in Type of Drug Coverage in 
Medicare Advantage Plans, 1999–2004 
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Note: With the exception of the January–February 2004 data, all other data is weighted by March enrollment of 
each year. January–February 2004 data is weighted by February 2004 enrollment. Information on generic-only 
prescription drug coverage was not tracked in 1999 and 2000. The number of enrollees with generic-only 
coverage during those two years is assumed to be negligible. 
Source: MPR Analysis of Medicare Compare for The Commonwealth Fund.  
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Table 3. Prescription Drug Coverage in Medicare Advantage Plans, 
by Type of Coverage Offered 
 Percentage of Enrollees 
Prescription Drug Coverage by Type 2001 2003 
Jan–Feb 
2004 
Mar–Dec
2004 
No Drug Coverage 29.9 31.2 31.1 28.7 
Percent Covering Generics Only 8.0 28.2 44.4 38.4 
Percent Covering Generics and Brand 62.1 40.6 24.8 32.9 
Generic Only Coverage     
$500 or less 4.6 19.1 6.5 3.0 
$501–$750 1.8 1.5 2.2 0.7 
$751–$1,000 8.2 0.0 1.4 0.3 
$1,001–$1,500 0.0 1.5 0.1 0.0 
$1,501–$2,000 0.0 0.0 2.5 0.9 
$2,001 or more 0.0 4.3 0.0 0.0 
No Cap 85.4 73.7 87.2 95.1 
Generic Copays     
None 0.0 0.0 2.8 1.1 
$10.00 or less 81.6 56.5 71.9 72.3 
$10.01 or more 18.4 43.5 25.4 26.6 
Brand and Generic Coverage     
$500 or less 19.7 20.5 33.8 34.6 
$501–$750 12.1 12.9 13.9 13.0 
$751–$1,000 11.9 29.9 19.7 8.9 
$1,001–$1,500 14.3 10.0 5.9 10.7 
$1,501–$2,000 24.6 18.6 12.1 7.3 
$2,001 or more 5.8 5.8 8.3 20.4 
No Cap 11.6 2.4 5.4 4.6 
Generic Copays     
None 8.8 9.7 11.9 17.0 
$10.00 or less 83.6 82.4 64.7 65.0 
$10.01 or more 7.6 8.0 23.4 18.0 
Brand Copays     
None 2.4 0.8 1.8 3.7 
$10.00 or less 21.7 5.9 8.8 8.9 
$10.01–$20.00 43.6 18.6 22.9 23.8 
$20.01 or more 32.3 74.7 66.5 63.8 
Note: With the exception of the January–February 2004 data, all other data is weighted by March enrollment 
of each year. January–February 2004 data is weighted by February 2004 enrollment. 
Source: MPR analysis of Medicare Compare for The Commonwealth Fund. 
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Table 4. Copayments for Medical and Hospital Services in MA Plans 
 Percentage of Enrollees 
 1999 2003 
Jan–Feb 
2004 
Mar–Dec 
2004 
Primary Care Physician     
None 18.0 7.1 9.9 15.1 
$5.00 or less 44.5 5.5 8.1 13.3 
$5.01–$10.00 32.1 45.6 39.9 43.7 
$10.01–$15.00 5.1 17.8 20.0 16.5 
$15.01 or more 0.3 24.0 22.2 11.4 
Specialty Physician     
None 15.9 4.1 4.1 6.0 
$5.00 or less 39.6 1.7 1.0 1.0 
$5.01–$10.00 26.8 11.8 10.3 22.6 
$10.01–$15.00 9.9 18.9 13.9 15.4 
$15.01 or more 1.2 63.5 70.7 55.0 
Varies 6.6 0.0 0.0 0.0 
Emergency Room     
None 6.5 3.0 2.3 1.8 
$20.00 or less 24.5 0.4 0.0 0.0 
$20.01–$40.00 30.5 5.9 3.2 3.3 
$40.01–$50.00 38.2 91.0 94.5 94.8 
$50.01 or more 0.2 0.0 0.0 0.0 
Any Cost Sharing     
Hospital Admission 4.3 82.1 85.7 82.1 
Hospital Outpatient 30.7 58.3 58.3 56.8 
X-Ray 7.5 17.9 36.2 34.3 
Lab 3.9 13.0 21.1 18.9 
Notes: With the exception of the January–February 2004 data, all other data is weighted by March enrollment of each 
year. January–February 2004 data is weighted by February 2004 enrollment. Many of the benefit descriptions for 
hospital outpatient, x-ray, and laboratory services provide a range of copayments. For instance, a plan could indicate 
that copayments for laboratory services range from $0 to $150. If zero was part of the range of copayments, the plan is 
characterized here as not requiring a copayment. 
Source: MPR Analysis of Medicare Compare for The Commonwealth Fund. 
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Table 5. Supplemental Benefits in MA Plans 
 Percentage of Enrollees 
 1999 2003 
Jan–Feb 
2004 
Mar–Dec 
2004 
Preventive Dental 69.9 19.4 16.5 20.5 
Vision Benefits 97.8 88.2 87.5 92.4 
Hearing Benefits 91.3 57.1 54.2 62.2 
Physical Exam 100.0 99.6 98.6 99.7 
Podiatry Benefits 26.9 26.9 28.0 29.6 
Chiropractic Benefits 20.9 4.8 2.3 3.5 
Note: With the exception of the January–February 2004 data, all other data is weighted by March enrollment 
of each year. January–February 2004 data is weighted by February 2004 enrollment. 
Source: MPR analysis of Medicare Compare for The Commonwealth Fund. 
 
 
 
 
 
Figure 4. Average Enrollee Out-of-Pocket Costs
in MA Plans, 1999–2004 
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Notes: With the exception of the January–February 2004 data, results are weighted by March enrollment
of each year. January–February 2004 data is weighted by February 2004 enrollment. Average costs assume
79 percent of enrollees are in good health, 15 percent in fair health, and 6 percent in poor health. This 
distribution corresponds to the distribution of self-reported health status among Medicare managed care 
enrollees in the 1999 Medicare Current Beneficiary Survey (Liu and Sharma 2003).
Source: MPR analysis of Medicare Compare data using HealthMetrix Research’s Medicare HMO Cost Share 
Report Methodology. 
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Table 6. Enrollee Out-of-Pocket Costs in Health Plans 
 1999 2003 
Jan–Feb 
2004 
Mar–Dec 
2004 
Percent 
Change from 
Jan–Feb 2004 
to 
Mar–Dec 2004
Total Cost Sharing      
All $975.64 $1,964.21 $2,119.35 $1,942.10 –8.4% 
Good $836.19 $1,564.48 $1,651.90 $1,495.71 –9.5% 
Fair $1,203.39 $2,695.70 $3,031.05 $2,798.32 –7.7% 
Poor $2,210.80 $5,305.28 $5,883.73 $5,573.42 –5.3% 
Premiums      
Annual Part B 
Premium 
$546.00 $704.40 $799.20 $799.20 0.0% 
Annual Plan 
Premium 
$63.37 $446.79 $394.76 $266.13 –32.6% 
Physician-Hospital Cost Sharing 
All $132.08 $301.04 $354.96 $317.27 –10.6% 
Good $117.08 $177.81 $191.95 $170.96 –10.9% 
Fair $159.41 $622.84 $786.62 $707.60 –10.0% 
Poor $257.81 $1,086.98 $1,379.52 $1,229.55 –10.9% 
Rx Cost Sharing 
All $234.19 $511.99 $570.43 $559.50 –1.9% 
Good $109.74 $235.48 $265.99 $259.42 –2.5% 
Fair $434.61 $921.67 $1,050.47 $1,025.39 –2.3% 
Poor $1,343.62 $3,067.11 $3,310.25 $3,278.54 –1.0% 
Notes: Results are weighted by plan enrollment in March of each year, with the exception of January–February 
2004, which is weighted by February 2004 plan enrollment. The “all” category assumes 79 percent of enrollees 
are in good health, 15 percent in fair health, and 6 percent in poor health. This distribution corresponds to the 
distribution of self-reported health status among Medicare managed care enrollees in the 1999 Medicare Current 
Beneficiary Survey (Liu and Sharma 2003). 
Source: MPR analysis of Medicare Compare data using HealthMetrix Research’s Medicare HMO Cost Share 
Report Methodology. 
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Table 7. Changes in Average Monthly Premiums 
by Payment Rate Category 
 Overall 
Rural 
Floor 
Urban 
Floor 
Minimum 
Increase 
Blended 
Increase 
100% FFS 
Rate 
2003 
Percent with 
Zero Premium 
38.5 22.9 28.7 65.2 0.0 36.9 
Percent with Premium 
$50 or more 
34.9 51.7 40.2 8.4 98.8 33.2 
Average Premium $37.40 $47.44 $40.26 $13.34 $81.44 $40.06 
Number of 
county enrollees 
4,546,635 111,599 1,191,481 1,074,337 369,885 1,799,333 
Jan–Feb 2004 
Percent with 
Zero Premium 
46.3 33.6 31.5 78.8 0.0 47.9 
Percent with Premium 
$50 or more 
32.4 47.2 34.8 4.4 98.7 32.2 
Average Premium $34.29 $44.52 $41.12 $9.00 $78.02 $33.35 
Number of county 
combinations/enrollees 
4,500,990 140,450 1,190,284 1,042,457 369,179 1,757,783 
Mar–Dec 2004 
Percent with 
Zero Premium 
55.7 35.3 36.8 85.6 0.0 64.1 
Percent with Premium 
$50 or more 
23.9 44.9 32.0 3.8 96.5 13.4 
Average Premium $25.31 $40.77 $35.81 $5.96 $63.53 $18.63 
Number of county 
combinations/enrollees 
4,503,282 144,430 1,190,875 1,040,868 369,326 1,757,783 
Notes: Results are weighted by plan enrollment in March, with the exception of January–February 2004, which is 
weighted by February 2004 plan enrollment. 
Source: MPR analysis of Medicare Compare for The Commonwealth Fund. 
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Table 8. Changes in Drug Coverage by Payment Rate Category, 2003–2004 
 
Overall 
Rural 
Floor 
Urban 
Floor 
Minimum 
Update 
Blended 
Increase 
100% FFS 
Rate 
2003       
No Coverage 31.2 85.7 47.4 21.6 1.4 28.9 
Generic Only 28.2 6.8 24.2 17.9 28.3 38.4 
Brand+Generic 40.6 7.5 28.5 60.5 70.3 32.7 
Jan–Feb 2004       
No Coverage 31.1 83.6 43.9 15.3 0.5 33.9 
Generic Only 44.3 7.7 31.1 47.6 98.3 42.9 
Brand+Generic 24.6 8.7 24.9 37.1 1.3 23.2 
Mar–Dec 2004       
No Coverage 28.7 83.6 42.1 14.8 0.5 29.3 
Generic Only 38.4 8.5 26.5 54.0 98.3 27.0 
Brand+Generic 32.9 7.9 31.4 31.2 1.3 43.7 
Notes: Results are weighted by plan enrollment in March of each year, with the exception of 
January–February 2004, which is weighted by February 2004 plan enrollment. 
Source: MPR analysis of Medicare Compare for The Commonwealth Fund. 
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Table 9. Number of MA Enrollees Who Saw Selected Changes in Benefits or Premiums 
as a Result of MMA Payment Increases 
 
Overall 
Rural 
Floor 
Urban 
Floor 
Minimum 
Increase 
Blended 
Increase 
100% FFS 
Rate 
Total Enrollees 4,0936,614 141,554 1,166,679 794,706 369,194 1,621,481 
Reduced Premium       
Yes 1,858,501 35,904 472,178 103,227 351,206 895,986 
No 2,235,113 105,650 694,501 691,479 17,988 725,495 
Enhanced Drug Coverage 
No Coverage to Brand and Generic Coverage 63,807 84 4,061 2,062 0 57,600 
No Coverage to Generic Only Coverage 43,851 328 18,846 5,842 0 18,835 
Increased Brand Limit 356,475 4,112 29,945 97,087 15 225,316 
Added Brand Coverage to Generic-Only Coverage 396,166 237 88,323 26,144 0 281,462 
Increased Generic Limit 100,259 177 57,123 0 1,567 41,392 
No Change 3,133,056 136,616 968,381 663,571 367,612 996,876 
Reduced Primary Care Physician Copay 
Yes 1,059,804 9,359 251,181 380,591 14,857 403,816 
No 3,033,810 132,195 915,498 414,115 354,337 1,217,665 
Eliminated Inpatient Hospital Cost Sharing 
Yes 91,095 0 0 59,395 15 31,685 
No 4,002,519 141,554 1,166,679 735,311 369,179 1,589,796 
Notes: Assumes enrollment in the basic plan. Numbers in this chart do not add up to the total number of enrollees in February 2004 because individuals whose basic 
plan changed from February 2004 to March 2004 were excluded from the analysis. The total number of enrollees excluded for this reason was 498,471. 
Source: MPR analysis of Medicare Compare for The Commonwealth Fund. 
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APPENDIX. DATA SOURCES AND METHODS 
 
This analysis of plan benefits and premiums relies on a database developed by 
Mathematica Policy Research (MPR) using information from Medicare Health Care 
Compare, a database of plan benefit packages maintained by the Centers for Medicare and 
Medicaid Services (CMS). Plans may offer more than one benefit package to enrollees; 
MPR defines the “basic package” as one with the lowest monthly premium or—if several 
have the same low premiums—the one with the best pharmacy benefits. The basic 
package is designed to offer insight on enrollees’ minimum coverage. 
 
Analyses presented in this report assign enrollment to the basic plan in each 
contract segment, using data from the Geographic Service Area File. (The data do not 
distinguish enrollees’ benefit package if a plan offers more than one package in an area.*) 
All results presented are weighted by enrollment. We included health maintenance 
organizations, non-demonstration preferred provider organizations and point-of-service 
plans, and provider service organizations in our analysis. 
                                                 
* The effect of assigning all enrollees to the basic plan is to understate coverage and premium levels, but 
doing so provides a consistent trend line for the most affordable option enrollees have to choose. 
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